Innovation Pharmaceuticals Inc (IPIX)

[Ernesto]

It's very possible we'll see new 52-week lows before we turn around but it doesn't really matter as long as we don't run out of cash. Our drug candidate portfolio is superb.

Then again, so was the Polymedix pipeline. There are dangers to flirting with cash problems. Fortunately we can just reverse split at any time for the uplist and make all these problems go away with no dilution or deals on crappy terms.